Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate

Kristina Stuopelyte; Rasa Sabaliauskaite; Arnas Bakavicius; Benedikta Haflidadottir; Tapio Visakorpi; Riina-Minna Väänänen; Chintan Patel; Daniel Danila; Hans Lilja; Juozas Lazutka; Albertas Ulys; Feliksas Jankevicius; Sonata Jarmalaite

doi:10.1097/ju.0000000000000803

Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate

Kristina Stuopelyte
, Rasa Sabaliauskaite
, Arnas Bakavicius
, Benedikta Haflidadottir
, Tapio Visakorpi
, Riina-Minna Väänänen
, Chintan Patel
, Daniel Danila
, Hans Lilja
, Juozas Lazutka
, Albertas Ulys
, Feliksas Jankevicius
, Sonata Jarmalaite

Department of Clinical Chemistry

Research output: Contribution to journal › Article › Scientific › peer-review

14 Citations (Scopus)

Original language	English
Pages (from-to)	71-78
Journal	Journal of Urology
Volume	204
Issue number	1
DOIs	https://doi.org/10.1097/ju.0000000000000803
Publication status	Published - 2020
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

AR
abiraterone
eturauhassyöpä
prostate cancer

Publication forum classification

Publication forum level 2

Access to Document

10.1097/ju.0000000000000803

Cite this

Stuopelyte, K., Sabaliauskaite, R., Bakavicius, A., Haflidadottir, B., Visakorpi, T., Väänänen, R.-M., Patel, C., Danila, D., Lilja, H., Lazutka, J., Ulys, A., Jankevicius, F., & Jarmalaite, S. (2020). Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate. Journal of Urology, 204(1), 71-78. https://doi.org/10.1097/ju.0000000000000803

@article{931c27e5e51a4d2c81e4cd01528fb119,

title = "Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate",

keywords = "AR, abiraterone, eturauhassy{\"o}p{\"a}, prostate cancer, AR, abiraterone, eturauhassy{\"o}p{\"a}, prostate cancer",

author = "Kristina Stuopelyte and Rasa Sabaliauskaite and Arnas Bakavicius and Benedikta Haflidadottir and Tapio Visakorpi and Riina-Minna V{\"a}{\"a}n{\"a}nen and Chintan Patel and Daniel Danila and Hans Lilja and Juozas Lazutka and Albertas Ulys and Feliksas Jankevicius and Sonata Jarmalaite",

year = "2020",

doi = "10.1097/ju.0000000000000803",

language = "English",

volume = "204",

pages = "71--78",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "1",

}

Stuopelyte, K, Sabaliauskaite, R, Bakavicius, A, Haflidadottir, B, Visakorpi, T, Väänänen, R-M, Patel, C, Danila, D, Lilja, H, Lazutka, J, Ulys, A, Jankevicius, F & Jarmalaite, S 2020, 'Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate', Journal of Urology, vol. 204, no. 1, pp. 71-78. https://doi.org/10.1097/ju.0000000000000803

TY - JOUR

T1 - Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate

AU - Stuopelyte, Kristina

AU - Sabaliauskaite, Rasa

AU - Bakavicius, Arnas

AU - Haflidadottir, Benedikta

AU - Visakorpi, Tapio

AU - Väänänen, Riina-Minna

AU - Patel, Chintan

AU - Danila, Daniel

AU - Lilja, Hans

AU - Lazutka, Juozas

AU - Ulys, Albertas

AU - Jankevicius, Feliksas

AU - Jarmalaite, Sonata

PY - 2020

Y1 - 2020

KW - AR

KW - abiraterone

KW - eturauhassyöpä

KW - prostate cancer

KW - AR

KW - abiraterone

KW - eturauhassyöpä

KW - prostate cancer

U2 - 10.1097/ju.0000000000000803

DO - 10.1097/ju.0000000000000803

M3 - Article

SN - 0022-5347

VL - 204

SP - 71

EP - 78

JO - Journal of Urology

JF - Journal of Urology

IS - 1

ER -